StreetAccount Summary - Trading higher/lower: EU mid-morning
SCHOTT Pharma upgraded to outperform from sector perform at RBC Capital Markets (€17.62, 0.00)
SCHOTT Pharma reports preliminary Q3 constant-currency revenue growth of ~8% (€17.62, 0.00)
SCHOTT Pharma upgraded to buy from hold at Deutsche Bank (€17.44, 0.00)
Powered by FactSet Research Systems Inc.